HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient.

AuthorsShu-Qing Ma, Jing Zhang, Yu-Shan Wang, Jun Xia, Peng Liu, Hong Luo, Ming-Yi Wang
JournalJournal of medical virology (J Med Virol) Vol. 92 Issue 11 Pg. 2396-2397 (11 2020) ISSN: 1096-9071 [Electronic] United States
PMID32470160 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Glucocorticoids
Topics
  • Antiviral Agents (therapeutic use)
  • Asymptomatic Infections (therapy)
  • COVID-19 (diagnostic imaging)
  • Female
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2 (drug effects)
  • Tomography, X-Ray Computed
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: